Healthcare - Biotechnology - NASDAQ - GB
$ 1.05
-1.87 %
$ 43.1 M
Market Cap
-0.66
P/E
BALANCE SHEET
161 M
ASSETS
19.1 M
LIABILITIES
142 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Achilles Therapeutics plc
| Current Assets | 146 M |
| Cash & Short-Term Investments | 132 M |
| Receivables | 10.4 M |
| Other Current Assets | 3.74 M |
| Non-Current Assets | 15.8 M |
| Long-Term Investments | 33 K |
| PP&E | 13.5 M |
| Other Non-Current Assets | 2.25 M |
| Current Liabilities | 17 M |
| Accounts Payable | 5.63 M |
| Short-Term Debt | 3.54 M |
| Other Current Liabilities | 7.83 M |
| Non-Current Liabilities | 2.09 M |
| Long-Term Debt | 1.08 M |
| Other Non-Current Liabilities | 1.02 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 131.5 | 173.3 | 266.3 | 177.8 | 97.6 | 10.7 |
| Short Term Investments | 0 | 0 | 0 | 0 | 265 | 0 |
| Receivables | 10.4 | 16.0 | 11.2 | 7.3 | 4.5 | 0 |
| Inventory | 1 | 4.6 | 5.1 | 1.8 | 0.5 | 0 |
| Other Current Assets | 3.7 | 7.2 | 7.3 | 2.6 | 1.0 | 2.7 |
| Total Current Assets | 145.6 | 196.6 | 284.7 | 187.8 | 103.1 | 13.4 |
| PP&E | 13.5 | 20.5 | 28.8 | 28.1 | 2.1 | 0.6 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 33 K | 33 K | 33 K | 0 | 0 | 0 |
| Other Long Term Assets | 2.2 | 3.0 | 3.5 | 3.0 | 34 K | 0 |
| Other Assets | 1 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 161.5 | 220.4 | 317.1 | 218.9 | 105.2 | 14.0 |
| LIABILITIES | ||||||
| Accounts Payable | 5.6 | 5.2 | 3.7 | 6.3 | 0.9 | 0.1 |
| Short Term Debt | 3.5 | 4.2 | 4.5 | 3.7 | 0.5 | 0 |
| Other Current Liabilities | 7.8 | 8.3 | 10.9 | 6.6 | 2.5 | 1.2 |
| Total Current Liabilities | 17.0 | 18.0 | 19.1 | 16.6 | 3.9 | 1.3 |
| Long Term Debt | 1.1 | 4.4 | 7.8 | 12.3 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 1.0 | 0.9 | 0.7 | 0.7 | 0 | 0 |
| Total Liabilities | 19.1 | 23.3 | 27.6 | 29.5 | 3.9 | 1.3 |
| EQUITY | ||||||
| Common Stock | 0.2 | 54 K | 54 K | 25 K | 14 K | 0 |
| Retained Earnings | (260.0) | (190.3) | (119.1) | (58.0) | (24.8) | (10.8) |
| Other Accumulative Comprehensive Income/Loss | (13.1) | (21.7) | 6.6 | 12.3 | 8.1 | (0.4) |
| Total Equity | 142.4 | 197.0 | 289.5 | 189.4 | 101.3 | 12.7 |
| Total Liabilities and Equity | 161.5 | 220.4 | 317.1 | 218.9 | 105.2 | 14.0 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 40.0 | 39.1 | 28.7 | 40.6 | 1.6 | 0.5 |